University of California, San Diego
ucsd.eduLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
963
Active
249
Phase 3
39
Total enrollment
434,361
Pipeline matrix
Showing 40 of 114 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Suzetrigine | — | — | — | — | — | 2 | |
| vancomycin | — | — | — | — | — | 2 | |
| Omeprazole 40 MG | — | — | — | — | — | 1 | |
| Popliteal nerve block including liposomal bupivacaine | — | — | — | — | — | 1 | |
| Adductor canal nerve block including liposomal bupivacaine | — | — | — | — | — | 1 | |
| Continuous popliteal nerve block with normal saline | — | — | — | — | — | 1 | |
| Popliteal nerve block with exclusively unencapsulated bupivacaine | — | — | — | — | — | 1 | |
| Adductor canal nerve block with exclusively unencapsulated bupivacaine | — | — | — | — | — | 1 | |
| Continuous popliteal nerve block with unencapsulated bupivacaine | — | — | — | — | — | 1 | |
| Dupilumab | — | — | — | — | — | 1 | |
| Benralizumab | — | — | — | — | — | 1 | |
| Multimodal Pain Management | — | — | — | — | — | 1 | |
| single injection nerve block | — | — | — | — | — | 1 | |
| 0.2% ropivacaine local anesthetic continuous erector spinae plane block | — | — | — | — | — | 1 | |
| 0.2% ropivacaine local anesthetic superficially taped continuous erector spinae plane block | — | — | — | — | — | 1 | |
| Spinal Morphine | — | — | — | — | — | 1 | |
| Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL | — | — | — | — | — | 1 | |
| Intraosseous Vamcomycin Administration | — | — | — | — | — | 1 | |
| Standard Care | — | — | — | — | — | 1 | |
| Testosterone Cypionate 50 milligrams per millileter (mg/mL) Injectable Solution | — | — | — | — | — | 1 | |
| Tranexamic Acid | — | — | — | — | — | 1 | |
| Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT] | — | — | — | — | — | 1 | |
| Emtricitabine / Tenofovir Disoproxil Oral Tablet 200/300 mg | — | — | — | — | — | 1 | |
| Emtricitabine Tenofovir Alafenamide 200/25 mg | — | — | — | — | — | 1 | |
| Experimental continuous peripheral nerve blocks | — | — | — | — | — | 1 | |
| Control continuous peripheral nerve blocks | — | — | — | — | — | 1 | |
| Continuous Infusion of ropivacaine 0.2% | — | — | — | — | — | 1 | |
| Titratable Automated Intermittent Boluses of ropivacaine 0.2% | — | — | — | — | — | 1 | |
| Clevidipine | — | — | — | — | — | 1 | |
| Lactated Ringers, Intravenous | — | — | — | — | — | 1 | |
| Sotagliflozin Low Dose | — | — | — | — | — | 1 | |
| Sotagliflozin High Dose | — | — | — | — | — | 1 | |
| Cannabidiol oral solution | — | — | — | — | — | 1 | |
| PharmaNord Bio-Quinone Active CoQ10 Gold 100mg | — | — | — | — | — | 1 | |
| PharmaNord Placebo | — | — | — | — | — | 1 | |
| Acetazolamide | — | — | — | — | — | 6 | |
| Medi-TBS | — | — | — | — | — | 2 | |
| THC | — | — | — | — | 2 | ||
| Rituximab | — | — | — | — | — | 4 | |
| REMD-477 | — | — | — | — | — | 3 |
74 more active programs hidden
Next readouts
- 2021-11-30
- 2023-05-01
- 2023-12-31
- 2024-01-31
- 2024-06-30
- 2024-07-17
- 2024-12
- 2024-12-31
- 2025-02-28
- 2025-07-22
Top conditions
- Obesity34
- Obstructive Sleep Apnea26
- Schizophrenia25
- Depression24
- Breast Cancer20
- HIV19
- Contraception18
- Anorexia Nervosa18
Frequently asked questions about University of California, San Diego
- How many clinical trials does University of California, San Diego have on ClinicalTrials.gov?
- University of California, San Diego is listed as the lead sponsor on 963 clinical trials in ClinicalTrials.gov, 249 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of California, San Diego's trials are in Phase 3?
- 39 of University of California, San Diego's trials are in Phase 3, spread across 114 active drug programs.
- What therapeutic areas does University of California, San Diego focus on?
- University of California, San Diego's most-studied conditions on ClinicalTrials.gov are Obesity, Obstructive Sleep Apnea, Schizophrenia, Depression, Breast Cancer.
- When are University of California, San Diego's next clinical trial readouts?
- University of California, San Diego has 10 upcoming primary-completion readouts tracked here; the soonest is “Directed Use of REmote Patient Management System AMia to Achieve Prescribed Dry Weight”, expected around 2021-11-30.